A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
WHAT THE GUIDELINES SAY According to the latest ESC guidelines for the treatment of acute coronary syndrome (ACS) patients (1) treatment recommendations are as follows: Aspirin (acetylsalicylic acid) is recommended for all ACS patients without contraindications. The initial oral loading dose (LD) is 150-300 mg in aspirin-naive patients, the maintenance dose (MD) is 75-100 mg/day. Aspirin is usually combined with a P2Y12-inhibitor, whereby prasugrel (60 mg LD or ticagrelor are preferred overdoi:10.22514/sv133.062017.9 fatcat:kz653skkbrcvbgd7l3bthhqhv4